Press Releases

Dec 27, 2018
Covalon Announces Issuance of Stock Options
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Dec. 27, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announces the issuance of an aggregate of 425,000 stock options to staff of the Company.
Dec 17, 2018
Covalon Announces Fiscal 2018 Year-End Results and Plans for Fiscal 2019
Fiscal 2018 profitable with $0.07 EPS on $26.7 million of revenue. Fiscal 2019 contracted Middle East revenue expected to be approximately $30 million , more than double the contracted revenue of fiscal 2018. Fiscal 2019 acquisition of AquaGuard more than doubles United States revenue to
Dec 17, 2018
Covalon Announces Conference Call to Discuss Year-End and Fourth Quarter Financial Results
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Dec. 17, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF), an advanced medical technologies company, will release its Fiscal 2018 Fourth Quarter and Year-End financial results concurrently on Monday December 17 th , 2018,
Oct 30, 2018
Covalon Announces Successful Completion of Operational Integration of AquaGuard Acquisition amid Continued Business Progress
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Oct. 30, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announces that it has successfully completed the integration of AquaGuard with its operations.
Oct 24, 2018
Covalon to Showcase AquaGuard® and IV Clear™ Products to Over 9,000 Nurses at Prestigious ANCC Magnet Conference
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Oct. 24, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV) (OTCQX:CVALF), an advanced medical technologies company, today announces that it will be showcasing newly-acquired moisture barrier line AquaGuard ® as part of its portfolio of
Oct 01, 2018
Covalon Announces Closing of AquaGuard Acquisition Combining Covalon’s Rich Technology Portfolio with AquaGuard’s Excellent Products and Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United States
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Oct. 1, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it has closed the acquisition (the “Closing”) of AquaGuard, the Seattle, Washington -based division
Sep 28, 2018
Covalon Announces Issuance of Stock Options
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Sep. 28, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV.V)(OTCQX:CVALF), an advanced medical technologies company, today announced the issuance of an aggregate of 155,000 stock options to directors, officers and staff of the Company.
Sep 20, 2018
Covalon to Host Conference Call to Discuss Definitive Agreement to Acquire AquaGuard
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Sep. 20, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has scheduled a conference call for Friday September 21 st 2018 at 9:00am EST .
Sep 20, 2018
Covalon Announces Definitive Agreement to Acquire AquaGuard and its Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United States
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Sep. 20, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV.V; OTCQX: CVALF), an advanced medical technologies company, today announces that it has entered into a definitive agreement to acquire AquaGuard, the Seattle, Washington -based
Sep 14, 2018
Covalon to Showcase IV Clear at AVA Scientific Meeting 2018
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Sep. 14, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV.V; OTCQX: CVALF), an advanced medical technologies company, today announces that it will be showcasing IV Clear at the 2018 Scientific Meeting for the Association for Vascular
Aug 28, 2018
Covalon Announces Another Milestone Quarterly Profit on Excellent Third Quarter Financial Results
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Aug. 28, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce today another milestone quarterly profit of $2.2 million on excellent third quarter financial
Aug 20, 2018
Covalon Announces Receipt of First Payment Under New License Agreement
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Aug. 20, 2018-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it has received $3.5 million USD under a new license agreement (“Agreement”) with a large global
Aug 09, 2018
Covalon Announces Major Banking Milestone
• New $17 million acquisition and operating banking facility with major international bank HSBC and Export Development Canada . • Credit facility will allow Covalon to fund its acquisition plans which are proceeding well. MISSISSAUGA, Ontario --(BUSINESS WIRE)--Aug.
Aug 07, 2018
Covalon Unaware of Any Material Change
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Aug. 7, 2018-- At the request of the Investment Industry Regulatory Organization of Canada (“IIROC”), Covalon Technologies Ltd. (“Covalon” or the “Company”) wishes to confirm that the Company’s management is unaware of any material change in the Company’s
Jul 26, 2018
Covalon Announces Retirement of Member of Board of Directors
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Jul. 26, 2018-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announces that Martin Bernholtz has retired as a member of the Board of Directors of the Company, effective at
Jun 12, 2018
Covalon Technologies Ltd. to Exhibit at the Largest Annual Infection Prevention and Control Conference in the World
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Jun. 12, 2018-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will exhibit at the APIC 2018 Conference in Minneapolis, Minnesota , June 13 th to 15 th .
May 28, 2018
Covalon Announces Major Corporate Initiatives and Second Quarter Results
Special Committee of the Board formed to evaluate acquisitions, strategic alliances, and partnerships as a result of recent announcement of $100 million in contract awards Significant progress is being made on the evaluation of potential accretive acquisitions Covalon to consider the potential for
May 28, 2018
Covalon to Host Conference Call to Discuss Release of Q2 Results and Initiatives
MISSISSAUGA, Ontario --(BUSINESS WIRE)--May 28, 2018-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV:COV; OTCQX:CVALF) an advanced medical technologies company, has scheduled a conference call for Tuesday May 29 th 2018 at 9:00 am ET .
May 22, 2018
Covalon Provides Further Information Regarding Estimated $100 Million Competitive Contract Awards
Covalon wins every single Vascular Access dressing category for the next three years in the Gulf Cooperation Council States in the Middle East MISSISSAUGA, Ontario --(BUSINESS WIRE)--May 22, 2018-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV:COV; OTCQX:CVALF), an advanced medical
May 07, 2018
Covalon Announces Major Sales Breakthrough – Wins Contracts with an Estimated Value of $100 Million Over a Three-Year Period
Conference call scheduled for Tuesday May 8 th at 9am EDT to discuss the impact of this major transformative event MISSISSAUGA, Ontario --(BUSINESS WIRE)--May 7, 2018-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has
Apr 30, 2018
Covalon to Showcase MediClear™ PreOp at AATS 2018 Annual Meeting
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Apr. 30, 2018-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be showcasing its perioperative suite of innovative products, including MediClear™
Apr 26, 2018
New Clinical Data for Covalon’s ColActive® Line of Patented Advanced Wound Care Products to be Presented at SAWC Spring
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Apr. 26, 2018-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV), an advanced medical technologies company, today announced that two clinical case studies demonstrating the clinical effectiveness of ColActive ® Plus and ColActive ®
Apr 18, 2018
Covalon Unaware of Any Material Change
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Apr. 18, 2018-- At the request of the Investment Industry Regulatory Organization of Canada (“IIROC”), Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), wishes to confirm that the Company’s management is unaware of any
Mar 26, 2018
Covalon to Feature MediClear™ PreOp at AORN Surgical Conference and Expo 2018
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Mar. 26, 2018-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be featuring its perioperative suite of innovative products including MediClear ™ PreOp
Mar 09, 2018
Covalon Announces Voting Results from 2018 Annual Meeting of Shareholders
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Mar. 9, 2018-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV), an advanced medical technologies company, today announced the results of the matters voted upon at the Company’s 2018 Annual Meeting of Shareholders held March 8 th 2018.
Mar 05, 2018
Covalon’s MediClear™ PreOp Receives Frost & Sullivan’s 2018 North American Surgical Site Infection Prevention New Product Innovation Award
MediClear PreOp is a novel pre-operative film drape designed to reduce the level of bacteria on a patient’s skin before a surgical procedure. Frost & Sullivan is a global research organization that monitors more than 300 industries and 25,000 companies. MISSISSAUGA, Ontario --(BUSINESS WIRE)--Mar.
Mar 01, 2018
Covalon Annual Shareholders’ Meeting to be Held Thursday March 8th 2018 at 3:30pm EST
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Mar. 1, 2018-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), announced a reminder that the Company’s Annual and Special Shareholders’ Meeting will be held at the offices of Stikeman Elliott LLP , 53 rd floor, Commerce
Feb 20, 2018
Covalon Announces its Participation in Medical Japan 2018
Covalon to showcase its proprietary advanced wound and infection control products as part of the Ontario Government’s Life Sciences Trade Mission to Japan . Medical Japan is the country’s largest trade show focusing on products, services and technologies for healthcare.
Feb 12, 2018
Covalon Announces Strong First Quarter Financial Results
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Feb. 12, 2018-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced today its first quarter financial results. First Quarter Summary Financial Results Revenue for the three
Feb 09, 2018
Covalon Announces Conference Call to Discuss Q1 Financial Results
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Feb. 9, 2018-- Covalon Technologies Ltd.  (the "Company" or " Covalon ") (TSXV: COV), an advanced medical technologies company, has scheduled a conference call to be held Tuesday February 13 th 2018 at 9:00 a.m.
Feb 05, 2018
Covalon to Showcase Centaur™ Low Particulate, Lubricious Coating at MD&M West
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Feb. 5, 2018-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV), an advanced medical technologies company, today announced that it will be featuring its commercially available platform technologies, including the recently launched Centaur™
Jan 24, 2018
Covalon Announces Issuance of Stock Options
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Jan. 24, 2018-- Further to its press release dated October 27, 2017 , Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the second tranche issuance of a further 60,000